developed a novel method to treat glioma cells by using hypoxia-responsive ionizable liposome-carrying anti-PLK1 siRNA that enhanced cellular uptake of siRNA, inducing a significant decrease in glioma cell proliferation both in vitro and in vivo.256. The gene discussed is PLK1; the disease is central nervous system cancer.